The linkage between FLT3 and HSP90, HSP110, and BIM expression in primary AML specimen suggests that a pharmacologically amenable control of FLT3-ITD by TPDs hits general mechanisms of leukemogenesis. Here, FLT3 is linked to acute myeloid leukemia.